News and Events: Full Listing

2017

11/7/2017:  TransMed7 receives U.S. Patent No. 9,808,226 for SpeedBird soft tissue biopsy platform technology.

10/17/2017:  TransMed7 announces 510(k) Submission to the FDA for its SpeedBird Soft Tissue Biopsy Device Platform.

10/10/2017:  TransMed7, LLC announces the appointment of Michael J. Demeure, MD FACS, FACE, MBA as Chair of our Endocrine and Gastrointestinal (GI) Health Team and Member of the Executive Team of TransMed7’s Clinical and Scientific Advisory Board (CSAB).

9/25/2017:  TransMed7, LLC announces the appointment of Richard E. Fine, MD FACS, as Chair, Breast Health Team and Member, Executive Team of TransMed7’s Clinical and Scientific Advisory Board (CSAB).

9/11/2017:  TransMed announces a Strategic Partnership with Peridot Corporation effecitve August 21, 2017.

7/24/2017:  Jack W. Cumming joins TransMed7, LLC as a member of the Board of Directors.

7/5/2017:  TransMed7 receives Notice of Allowance from the USPTO for Patent Application 13/853,806 for SpeedBird Soft Tissue Biopsy Platform Technology.

7/1/2017:  Dr. Edgar D. Staren joins TransMed7 as President of the company.  Dr. Staren also joins as President of Martinet Medical, LLC a subsidiary Project Company of TransMed7 focused on the development of a novel whole-lumpectomy technology platform medical device.

3/26-3/30, 2017:  TransMed7 highlights its SpeedBird, Martinet and Cardinal technologies at the annual meeting of the American Society of Breast Surgeons (ASBrS) in Las Vegas.

ASBrS ppt picture

2/22/2017:  TransMed7 receives Notice of Issuance for US Patent No. 9,592,035 for SpeedBird soft tissue biopsy platform technology.  The patent will be issued on March 14, 2017.

2/11/2017:  TransMed7 appoints Dr. Shawna C. Willey, MD, FACS as a Member of our Scientific and Clinical Advisory Board.

1/2/2017:  TransMed7 appoints Dr. Edgar D. Staren, MD, FACS, PhD, MBA as a Member of our Scientific and Clinical Advisory Board.

2016

10/11/2016:  TransMed7 receives US Patent No. 9,463,001 B2 for SpeedBird soft tissue biopsy platform technology.

10/4/2016:  TransMed7 receives US Patent No. 9,456,807 B2 for SpeedBird soft tissue biopsy platform technology.

9/15/2016:  TransMed7 receives Notice of Issuance for US Patent No. 9,456,807 corresponding to Patent Application No. 14/052,727 for SpeedBird soft tissue biopsy platform technology.  The patent will be issued on October 4, 2016.

9/16/2016:  TransMed7 receives Patent No. 6007256 from Japan for SpeedBird soft tissue biopsy platform technology.

9/6/2016:  TransMed7 receives Notice of Allowance for JP Patent Application 2014-535965 from Japan for SpeedBird soft tissue biopsy platform technology.

9/3/2016:  TransMed7 appoints Dr. Tomoaki Hinohara, MD as a Member of our Scientific and Clinical Advisory Board.

8/10/2016:  TransMed7 appoints Dr. Lorraine Tafra, MD, FACS as a Member of our Scientific and Clinical Advisory Board.

8/10/2016:  TransMed7 appoints Dr. David H. Deaton, MD, FACS as a Member of our Scientific and Clinical Advisory Board.

8/1/2016:  TransMed7 appoints Dr. Sally J. Vetter, MD as a Member of our Scientific and Clinical Advisory Board.

8/1/2016:  TransMed7 appoints Dr. Victor Chen, MD as a Member of our Scientific and Clinical Advisory Board.

7/27/2016:  TransMed7 receives USPTO Notice of Allowance for patent application 13/903,800 for SpeedBird soft tissue biopsy platform technology.

7/25/2016:  TransMed7 receives USPTO Notice of Allowance for patent application 14/052,727 for SpeedBird soft tissue biopsy platform technology.

6/30/2016:  TransMed7 appoints Tracy A. Sykes as a Member of the Board of Directors.

6/15/2016:  TransMed7 receives Patent No. ZL201280060967.8 from the People’s Republic of China for SpeedBird soft tissue biopsy platform technology.

4/30/2016:  TransMed7 appoints Beth A. Boyd, RN as a Member of our Scientific and Clinical Advisory Board.

4/30/2016:  TransMed7 appoints Dr. Richard E. Fine, MD, FACS as a Member of our Scientific and Clinical Advisory Board.

2/21/2016:  TransMed7 appoints Dr. Greg Robertson, MD as a Member of our Scientific and Clinical Advisory Board.

2/16/2016:  TransMed7 receives Patent No. 9,259,211B2 for Martinet lumpectomy platform technology.

2/4/2016:  TransMed7 launches its first cardiovascular platform technology Project LLC:  Corsair CV, LLC.

2015

10/29/2015:  TransMed7 appoints Jeffrey C. Coyne as General Counsel and Member of the Board of Directors.

10/13/2015:  TransMed7 receives Patent No. 9,155,527B2 for SpeedBird soft tissue biopsy platform technology.

5/26/2015:  TransMed7 receives Patent No. 9,039,633B2 for Martinet lumpectomy platform technology.

3/31/2015:  TransMed7 receives Patent No. 8,992,441B2 for Martinet lumpectomy platform technology.

2014

(Archived)

2013

(Archived)

2012

(Archived)

2011

7/1/2011:  TransMed7 appoints Dr. Alisen E. Vetter, DVM, PhD as Project Manager for SpeedBird, LLC.  Dr. Vetter also serves as President of SpeedBird, LLC.

4/4/2011:  Alan Young of Alan Young Law Firm joins TransMed7 as our lead Intellectual Property attorney.

3/16/2011:  TransMed7 appoints Charles R. Rodondi, CPA as Comptroller for TransMed7, LLC.

3/8/2011:  TransMed7 launches its first Project LLC, SpeedBird, LLC, to develop a platform of new soft tissue biopsy devices.


Corporate Archives are available to TransMed7, LLC Member Shareholders